Prism Medico board to meet on May 28 to consider Q4 FY26 results
Prism Medico and Pharmacy Limited will hold a board meeting on May 28, 2026, to approve the audited standalone financial results for the quarter and fiscal year ended March 31, 2026. The meeting will also cover the review of the Auditors Report and other routine business.

*this image is generated using AI for illustrative purposes only.
Prism Medico and Pharmacy Limited has announced that its board meeting is scheduled to take place on May 28, 2026. The meeting will be held at the company's registered office located at Suketi Road, Kala Amb, Sirmaur, Himachal Pradesh, starting at 3:00 PM.
The primary agenda for the meeting involves the consideration and approval of the audited standalone financial results for the company. Specifically, the board will review the performance for the quarter and financial year ended March 31, 2026, along with the Auditors Report. This disclosure is being made in compliance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Agenda Details
The board will deliberate on the following key points during the session:
- Consider, approve, and take on record the Audited Standalone Financial Results for the quarter and financial year ended March 31, 2026.
- Review the Auditors Report accompanying the financial results.
- Discuss any other routine matters or business of the company.
Meeting Information
| Details | Information |
|---|---|
| Date | May 28, 2026 |
| Time | 03:00 P.M. |
| Venue | Registered Office, Suketi Road, Kala Amb, Sirmaur, Himachal Pradesh-173030 |
| Purpose | Consideration of Audited Financial Results for Q4 and FY26 |
The intimation regarding this meeting has been sent to the stock exchanges, including BSE Limited and Metropolitan Stock Exchange of India Limited, to ensure regulatory compliance. Shareholders and market participants can await the official announcement of the financial results following the conclusion of the board meeting.
Historical Stock Returns for Prism Medico & Pharmacy
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -4.97% | -0.14% | -13.67% | +49.37% | +69.20% | +159.07% |
How has Prism Medico and Pharmacy Limited's revenue and profitability trended over the past few quarters leading into FY26 results?
Will the board consider announcing any dividend distribution or capital allocation strategy following the approval of FY26 audited results?
Are there any expansion plans or strategic initiatives in the pharmaceutical sector that Prism Medico may announce alongside its annual financial results?


































